FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 87 filers reported holding FORTRESS BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $36,000 | -45.5% | 26,240 | 0.0% | 0.00% | – |
Q4 2021 | $66,000 | -24.1% | 26,240 | -3.0% | 0.00% | – |
Q3 2021 | $87,000 | -10.3% | 27,040 | 0.0% | 0.00% | – |
Q2 2021 | $97,000 | -9.3% | 27,040 | -10.7% | 0.00% | – |
Q1 2021 | $107,000 | -54.9% | 30,295 | -59.4% | 0.00% | – |
Q4 2020 | $237,000 | -10.9% | 74,683 | +13.4% | 0.00% | -100.0% |
Q3 2020 | $266,000 | +358.6% | 65,868 | +206.6% | 0.00% | – |
Q2 2020 | $58,000 | +123.1% | 21,480 | +48.1% | 0.00% | – |
Q1 2019 | $26,000 | +116.7% | 14,506 | 0.0% | 0.00% | – |
Q4 2018 | $12,000 | -47.8% | 14,506 | 0.0% | 0.00% | – |
Q3 2018 | $23,000 | -46.5% | 14,506 | 0.0% | 0.00% | – |
Q2 2018 | $43,000 | -49.4% | 14,506 | -22.2% | 0.00% | – |
Q1 2018 | $85,000 | +14.9% | 18,655 | 0.0% | 0.00% | – |
Q4 2017 | $74,000 | -9.8% | 18,655 | 0.0% | 0.00% | – |
Q3 2017 | $82,000 | -7.9% | 18,655 | 0.0% | 0.00% | – |
Q2 2017 | $89,000 | – | 18,655 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,000,000 | $580,600 | 0.19% |
Nantahala Capital Management | 6,018,211 | $1,747,087 | 0.15% |
THOMPSON DAVIS & CO., INC. | 12,996 | $3,773 | 0.01% |
Platform Technology Partners | 30,000 | $8,709 | 0.00% |
Black Maple Capital Management LP | 15,000 | $4,355 | 0.00% |
Arete Wealth Advisors, LLC | 52,547 | $15,254 | 0.00% |
B. Riley Wealth Advisors, Inc. | 144,700 | $42,006 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,075,531 | $311 | 0.00% |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 1,542,000 | $447,643 | 0.00% |
GROUP ONE TRADING, L.P. | 2,000 | $581 | 0.00% |